Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Subst Abuse Treat. 2014 Aug 23;0:1–7. doi: 10.1016/j.jsat.2014.08.003

Table 2. Perceived importance of innovation attributes in adoption decisions in the sub-sample of organizations with recent or planned adoption (n = 155).

Timing of Adoption Type of Innovation
CombinedSample Mean (SD) RecentAdoptionMean (SD) PlannedAdoptionMean (SD) Medication Mean (SD) Psychosocial Intervention Mean (SD)
Attract more clients to treatment at this facility 2.71 (1.96) 2.45 (1.96)* 3.10 (1.91) 2.93 (1.83) 2.63 (2.00)
Increase the treatment capacity of this center 2.52 (2.05) 2.21 (2.02)* 2.98 (2.02) 2.73 (1.87) 2.45 (2.11)
Increase the average length of stay in treatment 2.42 (1.97) 2.39 (2.05) 2.47 (1.85) 2.30 (1.80) 2.51 (2.02)
Reduce treatment drop-out rates 3.75 (1.54) 3.75 (1.59) 3.76 (1.47) 3.80 (1.51) 3.76 (1.53)
Improve staff morale 3.01 (1.72) 2.96 (1.73) 3.10 (1.72) 2.51 (1.75)* 3.16 (1.69)
Reduce staff turnover 2.16 (1.87) 2.04 (1.88) 2.34 (1.86) 1.75 (1.84)# 2.33 (1.88)
Low start-up costs 2.80 (1.92) 2.65 (1.98) 3.03 (1.83) 2.53 (1.95) 2.94 (1.90)
Low on-going costs 2.97 (1.92) 2.85 (2.01) 3.15 (1.78) 2.40 (1.79)* 3.19 (1.92)
Increase revenues received by this center from its funding sources 2.55 (1.98) 2.30 (1.98)# 2.92 (1.94) 2.75 (1.77) 2.43 (2.05)
Improve the reputation of this center among its referral sources in the community 4.00 (1.33) 3.87 (1.36) 4.19 (1.27) 4.10 (1.45) 3.95 (1.29)
Improve this center's reputation among clients and their families in the community 3.98 (1.31) 3.90 (1.37) 4.10 (1.21) 4.20 (1.29) 3.89 (1.32)
Consistent with this center's treatment philosophy 4.47 (1.03) 4.51 (1.00) 4.42 (1.08) 4.45 (1.08) 4.53 (0.92)
Would not require major changes to how the center operates 3.31 (1.75) 3.45 (1.70) 3.10 (1.82) 3.03 (1.67) 3.43 (1.76)
Easy to train staff to implement this intervention 3.46 (1.63) 3.44 (1.62) 3.48 (1.66) 3.13 (1.57) 3.59 (1.62)

Notes: Sub-sample consists of 155 organizations, but cell sizes vary based on missing data on the specific perceived importance measures. For the comparisons between recent and planned adopters, complete data were available from 154 to 155 organizations. Complete data were available from 152 to 153 organizations for the comparisons between those focused on medications versus psychosocial interventions. Differences between two groups,

#

p < .10,

*

p < .05 (two-tailed).